| Mark R Gildenhar, MD | |
|
1703 S Meridian, Suite 101, Puyallup, WA 98371 | |
| (253) 848-3000 | |
| (253) 840-6514 |
| Full Name | Mark R Gildenhar |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1703 S Meridian, Puyallup, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790796860 | NPI | - | NPPES |
| 8175408 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00017654 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark R Gildenhar, MD 1703 S Meridian, Suite 101, Puyallup, WA 98371 Ph: (253) 848-3000 | Mark R Gildenhar, MD 1703 S Meridian, Suite 101, Puyallup, WA 98371 Ph: (253) 848-3000 |
News Archive
When University of California, Berkeley, bioengineers say they are holding their hearts in the palms of their hands, they are not talking about emotional vulnerability.
A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory.
A team of engineers from the CEIT-IK4 technological centre and doctors from the University Hospital of Navarra have designed a new tool for operating on the inner ear with maximum precision, reducing the possibility of damage to the auditory function during the surgery. This is the first micromanipulator specifically for operations involving cochlear and middle ear implants, of which about a hundred are carried out in this hospital annually. Taking part in developing the new tool were four engineers from CEIT and five ear, nose and throat specialists from the University Hospital of Navarra.
A recent study led by A*STAR's Singapore Institute for Clinical Sciences (SICS) found that genetics as well as the environment in the womb play important roles in the development of the baby.
It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.
› Verified 7 days ago
Keith F Dahlhauser, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian, Suite 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-840-6514 | |
Rachael D Elrod, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1703 S Meridian, Suite 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-840-6514 | |
Michael B Brush, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1007 39th Ave Se, Puyallup, WA 98374 Phone: 253-435-3200 | |
Dr. Aimee Nguyen Lam, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian Ste 100, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-845-8750 | |
Dr. Adam G Buchanan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian Ste 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-845-8750 | |
Dr. Travis C Frazier, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian Ste 101, Puyallup, WA 98371 Phone: 253-848-3000 | |
Roy J Park, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 S Meridian Ste 101, Puyallup, WA 98371 Phone: 253-848-3000 Fax: 253-840-6514 |